Works matching AU NISKANEN, LEO


Results: 143
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18

    Increased cancer incidence in acromegaly – a nationwide survey.

    Published in:
    Clinical Endocrinology, 2010, v. 72, n. 2, p. 278, doi. 10.1111/j.1365-2265.2009.03619.x
    By:
    • Kauppinen-Mäkelin, Ritva;
    • Sane, Timo;
    • Välimäki, Matti J.;
    • Markkanen, Helene;
    • Niskanen, Leo;
    • Ebeling, Tapani;
    • Jaatinen, Pia;
    • Juonala, Markus
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Serum uric acid as a harbinger of metabolic outcome in subjects with impaired glucose tolerance: the Finnish Diabetes Prevention Study.

    Published in:
    2006
    By:
    • Niskanen L;
    • Laaksonen DE;
    • Lindström J;
    • Eriksson JG;
    • Keinänen-Kiukaanniemi S;
    • Ilanne-Parikka P;
    • Aunola S;
    • Hämäläinen H;
    • Tuomilehto J;
    • Uusitupa M;
    • Niskanen, Leo;
    • Laaksonen, David E;
    • Lindström, Jaana;
    • Eriksson, Johan G;
    • Keinänen-Kiukaanniemi, Sirkka;
    • Ilanne-Parikka, Pirjo;
    • Aunola, Sirkka;
    • Hämäläinen, Helena;
    • Tuomilehto, Jaakko;
    • Uusitupa, Matti
    Publication type:
    journal article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    Sulfonylurea receptor 1 gene variants are associated with gestational diabetes and type 2 diabetes but not with altered secretion of insulin.

    Published in:
    2000
    By:
    • Rissanen, Johanna;
    • Markkanen, Anu;
    • Kärkkäinen, Päivi;
    • Pihlajamäki, Jussi;
    • Kekäläinen, Päivi;
    • Mykkänen, Leena;
    • Kuusisto, Johanna;
    • Karhapää, Pauli;
    • Niskanen, Leo;
    • Laakso, Markku;
    • Rissanen, J;
    • Markkanen, A;
    • Kärkkäinen, P;
    • Pihlajamäki, J;
    • Kekäläinen, P;
    • Mykkänen, L;
    • Kuusisto, J;
    • Karhapää, P;
    • Niskanen, L;
    • Laakso, M
    Publication type:
    journal article
    41
    42
    43
    44

    GAD Antibodies in NIDDM.

    Published in:
    Diabetes Care, 1995, v. 18, n. 12, p. 1557, doi. 10.2337/diacare.18.12.1557
    By:
    • Niskanen, Leo K.;
    • Tuomi, Tiinamaija;
    • Karjalainen, Jukka;
    • Groop, Leif C.;
    • Uusitupa, Matti I. J.
    Publication type:
    Article
    45
    46
    47
    48
    49

    Empagliflozin Use Is Associated With Lower Risk of All‐Cause Mortality, Hospitalization for Heart Failure, and End‐Stage Renal Disease Compared to DPP‐4i in Nordic Type 2 Diabetes Patients: Results From the EMPRISE (Empagliflozin Comparative Effectiveness and Safety) Study

    Published in:
    Journal of Diabetes Research, 2024, v. 2024, p. 1, doi. 10.1155/2024/6142211
    By:
    • Langslet, Gisle;
    • Nyström, Thomas;
    • Vistisen, Dorte;
    • Carstensen, Bendix;
    • Grip, Emilie Toresson;
    • Casajust, Paula;
    • Tskhvarashvili, Giorgi;
    • Hoti, Fabian;
    • Klement, Riho;
    • Karlsdotter, Kristina;
    • Tuovinen, Mikko;
    • Ofstad, Anne Pernille;
    • Lajer, Maria;
    • Shay, Christina;
    • Koeneman, Lisette;
    • Farsani, Soulmaz Fazeli;
    • Niskanen, Leo;
    • Halvorsen, Sigrun;
    • Infante, Marco
    Publication type:
    Article
    50